Strategic
Lines of
Business

More and more novel therapies and treatments require the re-development of existing drugs. We’re enhancing drug formulation with our Premix™ medicines to match the current standard of care with products that are ready to use.




Surgical procedures invasivity and duration reduction and increased cost pressures on health systems are leading to a shift toward day surgery. Modern short and medium acting local anesthetics are our One Day Surgery® proposal to adapt the length and the conditions of anaesthesia to the novel surgical needs, allowing patients same day safe discharge.



We consider of outmost importance that patients when back home after surgery are again fully a citizen. This means that pain has to be managed at hospital as much as possible. Dual Spinal® is our development of an innovative pain killer drug to treat the acute pain after surgery at hospital, when inducing anaesthesia.



Enhance Intrathecal Therapy® is our promise to improve care in the neuromodulation.


We develop novel drugs and make available life-changing medicines to the largest number of patients and health care providers world-wide.

Strategic
Lines of
Business

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.